Utrecht Coronary Biobank (UCORBIO)
试验速览
- 阶段
- 不适用
- 发起方
- UMC Utrecht
- 入组人数
- 3,000
- 试验地点
- 1
- 主要终点
- major adverse cardiovascular events [MACE] (Stroke, myocardial infarction, coronary revascularization, death)
研究概览
简要总结
UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter.
At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Coronary angiography
排除标准
- •Age < 18 years.
结局指标
主要结局
major adverse cardiovascular events [MACE] (Stroke, myocardial infarction, coronary revascularization, death)
时间窗: 5 years
Stroke, myocardial infarction, coronary revascularization, death.
次要结局
未报告次要终点